SB2 Infliximab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SB2 Infliximab, covering 2017-10-13 to 2017-10-13. Get the full timeline:
Most recent: Clinical Trial Update: Comparison of the Performance of SB2-Infliximab With Originator Infliximab in the Measure of Serum Concentrations in Serum